IκB-α is the most abundant and ubiquitous inhibitor of NF-κB family [17], and acts as constitutive repressor of NF-κB and tumor suppressor when mutated to the proteolysis-resistant IκB-α S32/36A form [18], [19]. The gene discussed is NFKB1; the disease is neoplasm.